ARCKW [NASD]
Arbor Rapha Capital Bioholdings Corp. I
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-44.79%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-64.71%
Income- PEG- EPS next Q- Inst Own- Short Float / Ratio- / - Perf Quarter-91.00%
Sales- P/S- EPS this Y- Inst Trans- Short Interest- Perf Half Y-
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range0.01 - 0.60 Perf YTD-96.40%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-97.00% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low38.46% ATR0.02
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)42.06 Volatility10.02% 48.92%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.03 Prev Close0.01
ShortableNo LT Debt/Eq- Earnings- Payout- Avg Volume16.98K Price0.02
Recom- SMA20-73.31% SMA50-76.57% SMA200-91.48% Volume600 Change38.46%
Apr-01-22 06:41PM
Arbor Rapha Capital Bioholdings Corp. I intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the biopharmaceutical sector. The company was incorporated in 2021 and is based in Uniondale, New York.